Hemangiosarcoma was recently identified as the most important cancer diagnosis noted in the American golden retriever population. Hemangiosarcoma also is the most common cancer diagnosed in the Golden Retriever Lifetime Study cohort. Interestingly, the disease is less common in European golden retrievers, suggesting a hereditary component to the disease. Researchers will study the genomes of golden retrievers to identify mutations associated with development of hemangiosarcoma in the breed. Findings could lead to better treatments and diagnostic testing for this serious cancer.
Study ID
D23CA-527
Study Status
Active
Start Date
02/01/2023
Grant amount awarded
$50,000
Grant recipient
Utrecht University
Study country
Netherlands
Investigator
Hille Fieten, DVM, PhD